期刊
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
卷 30, 期 2, 页码 245-247出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/1055-9965.EPI-20-1538
关键词
-
资金
- Cancer Research UK [C8162/A16892, C8162/A27047]
Self-sampling has the potential to revolutionize cervical screening by enabling socially distanced screening and reaching underserved populations. Despite regulatory issues and communication hurdles, the introduction of self-sampling could lead to wider adoption, especially in the context of COVID-19.
Self-sampling is poised to be a disruptor for cervical screening. So far, cancer screening has been a causality of COVID-19; however, the opposite may transpire for self-sampling. Self-sampling enables socially distanced cervical screening with an outreach that extends to underserved populations. As evidence mounts that self-sampling is noninferior to clinician-taken samples, the focus for self-sampling is now as a primary screening option for all women. Now, we have evidence from a modeling study (using Australia as an exemplar) to suggest that program effectiveness with primary self-sampling would be better than the current program, even if sensitivity is lower. Regulatory issues, suitable triage strategies, and clear communication about self-sampling are hurdles yet to be overcome. Nevertheless, existing evidence coupled with COVID-19 could be the tipping point for wider introduction of self-sampling.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据